A five-year old British Columbia-based medical cannabis company just made its debut in the U.S. markets.

Tilray, which sell its products to patients, as well as researchers, governments, and pharmacies, opened on the NASDAQ on Thursday.

The company priced 9 million shares at $17 a share and they hit as high as $22.39. This represented an increase of 32%.

Tilray is the very first cannabis company to conduct an IPO in the United States. but cannot sell its products in the U.S. market, given that marijuana remains illegal under federal law.

So far 30 states and Washington, D.C. have legalized it in some form.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Against the Grain
28 March 2023
American Medical Association Adopts Cannabis Expungement Resolution
20 June 2022
Biden Administration to Issue New Guidelines on Staff and Past Marijuana Use
26 February 2021